phase readout
saveNCT05972551: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta
view source ↗
comments(0)
5-min edit window · permanent after that